Literature DB >> 9729619

cGMP inhibits IP3-induced Ca2+ release in intact rat megakaryocytes via cGMP- and cAMP-dependent protein kinases.

S Tertyshnikova1, X Yan, A Fein.   

Abstract

1. Inhibition of inositol 1,4,5-trisphosphate (IP3) receptor-mediated Ca2+ release by cGMP was examined in intact rat megakaryocytes, by using a combination of single cell fluorescence microscopy to monitor intracellular free calcium ([Ca2+]i) and flash photolysis of caged second messengers. 2. Sodium nitroprusside (SNP), a nitric oxide (NO) donor, and the hydrolysis-resistant cGMP analogue 8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphate (pCPT-cGMP) inhibited Ca2+ release induced by photolysis of caged IP3. Neither of them affected the rate of Ca2+ removal from the cytoplasm following photolysis of caged Ca2+. 3. Photolysis of the caged NO donor 3-morpholinosydnonimine (SIN-1) during agonist-induced [Ca2+]i oscillations inhibited Ca2+ release without affecting the rate of Ca2+ uptake and/or extrusion. 4. We conclude that the inhibition of IP3-induced Ca2+ release is the principal mechanism of NO-cGMP-dependent inhibition of [Ca2+]i mobilization. 5. IPG, a specific peptide inhibitor of cGMP-dependent protein kinase (cGMP-PK), blocked the inhibitory effect of pCPT-cGMP, indicating that the inhibition of IP3-induced Ca2+ release by pCPT-cGMP is mediated by cGMP-PK. However, the simultaneous application of both IPG and IP20, a specific peptide inhibitor of cAMP-dependent protein kinase (cAMP-PK), was required to block the inhibitory effect of SNP. These data strongly suggest that NO-cGMP-dependent inhibition of [Ca2+]i mobilization is mediated via the activation of both cGMP-PK and cAMP-PK.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729619      PMCID: PMC2231186          DOI: 10.1111/j.1469-7793.1998.089bf.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  Inositol 1,4,5-trisphosphate receptor is phosphorylated by cyclic AMP-dependent protein kinase at serines 1755 and 1589.

Authors:  C D Ferris; A M Cameron; D S Bredt; R L Huganir; S H Snyder
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

2.  Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium.

Authors:  S Supattapone; S K Danoff; A Theibert; S K Joseph; J Steiner; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Inhibition of inositol 1,4,5-trisphosphate-induced Ca2+ release by cAMP-dependent protein kinase in a living cell.

Authors:  S Tertyshnikova; A Fein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate.

Authors:  R Deana; M Ruzzene; M G Doni; F Zoccarato; A Alexandre
Journal:  Biochim Biophys Acta       Date:  1989-11-20

5.  The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

6.  Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.

Authors:  R Bowen; R J Haslam
Journal:  J Cardiovasc Pharmacol       Date:  1991-03       Impact factor: 3.105

7.  Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells.

Authors:  M Hirata; K P Kohse; C H Chang; T Ikebe; F Murad
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

8.  Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.

Authors:  D H Maurice; R J Haslam
Journal:  Mol Pharmacol       Date:  1990-05       Impact factor: 4.436

9.  Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates.

Authors:  R De Caterina; D Giannessi; W Bernini; A Mazzone
Journal:  Thromb Haemost       Date:  1988-04-08       Impact factor: 5.249

10.  Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.

Authors:  B J Whittle; S Moncada; F Whiting; J R Vane
Journal:  Prostaglandins       Date:  1980-04
View more
  16 in total

1.  Role of cyclic nucleotides in mediating the nitric oxide (II) effects on transmitter release and the electrogenesis of motor nerve endings.

Authors:  A V Yakovlev; G F Sitdikova; A L Zefirov
Journal:  Dokl Biol Sci       Date:  2002 Jan-Feb

2.  InsP3R-associated cGMP kinase substrate determines inositol 1,4,5-trisphosphate receptor susceptibility to phosphoregulation by cyclic nucleotide-dependent kinases.

Authors:  Wataru Masuda; Matthew J Betzenhauser; David I Yule
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

Review 3.  Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation.

Authors:  Veerle Vanderheyden; Benoit Devogelaere; Ludwig Missiaen; Humbert De Smedt; Geert Bultynck; Jan B Parys
Journal:  Biochim Biophys Acta       Date:  2008-12-16

4.  Activation of the cGMP/PKG pathway inhibits electrical activity in rabbit urethral interstitial cells of Cajal by reducing the spatial spread of Ca2+ waves.

Authors:  G P Sergeant; Louise Johnston; N G McHale; K D Thornbury; M A Hollywood
Journal:  J Physiol       Date:  2006-04-27       Impact factor: 5.182

5.  Dual regulation of calcium mobilization by inositol 1,4, 5-trisphosphate in a living cell.

Authors:  S Tertyshnikova; A Fein
Journal:  J Gen Physiol       Date:  2000-04       Impact factor: 4.086

6.  Changes in the spontaneous calcium oscillations for the development of the preconditioning-induced ischemic tolerance in neuron/astrocyte co-culture.

Authors:  Motoki Tanaka; Koichi Kawahara; Tatsuro Kosugi; Takeshi Yamada; Tetsuo Mioka
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

Review 7.  Linking structure to function: Recent lessons from inositol 1,4,5-trisphosphate receptor mutagenesis.

Authors:  David I Yule; Matthew J Betzenhauser; Suresh K Joseph
Journal:  Cell Calcium       Date:  2010-05-26       Impact factor: 6.817

8.  Regulation of glucose transport in aortic smooth muscle cells by cAMP and cGMP.

Authors:  C J MacKenzie; J M Wakefield; F Cairns; A F Dominiczak; G W Gould
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

9.  IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase.

Authors:  Angela Geiselhöringer; Matthias Werner; Katja Sigl; Petra Smital; René Wörner; Linda Acheo; Juliane Stieber; Pascal Weinmeister; Robert Feil; Susanne Feil; Jörg Wegener; Franz Hofmann; Jens Schlossmann
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

10.  Effect of cGMP on pharmacomechanical coupling in the uterine artery of near-term pregnant sheep.

Authors:  Lubo Zhang; Daliao Xiao; Xiangqun Hu
Journal:  J Pharmacol Exp Ther       Date:  2008-08-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.